Body of Research

A review of the potential of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), concludes that targeting the anti-inflammatory properties of the vagus nerve with VNS could be of interest in the management of patients with IBD involving the digestive tract through a non-drug therapy. About 1.5 million Americans and 2.2 million people in Europe are affected by IBD. There is a rising incidence of IBD in Western countries, supporting the hypothesis that “Westernization” of our li...

Several studies investigating the use of transcutaneous vagus nerve stimulation (tVNS) for disorders tinnitus, migraine and pain show therapeutic effects similar to those produced by the more invasive direct vagus nerve stimulation (VNS). Although VNS is an FDA-approved therapy for the treatment of both depression and epilepsy, it is limited to being a second or third-line treatment option for severe, intervention-resistant cases, due to risks involved with device implantation. In contrast, t...

The only place on the body where the vagus nerve (VN) sends its only peripheral branch is on the outer ear. The auricle is where this VN branch surfaces to form a cutaneous receptive field in the pinna of the ear — an area responsive to peripheral nerve stimulation. Thus, the auricle allows for easy access for auricular (and transcutaneous auricular) vagus nerve stimulation (aVNS/taVNS), that relays the stimuli to the brainstem and higher brain regions via extensive projections to second and...